Physician profile
Taylor Flick
NPI 1598292740
$11,673.21
in general payments reported to CMS, 2019-2025
50 companies · $3,502 in 2025
The $3,502 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,039 · 2022: $2,013 · 2023: $1,955 · 2024: $2,164 · 2025: $3,502.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,255 · Education: $366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,255.26 |
| Education | $366.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $2,374.61 | 2021-2025 | Austedo Xr, Austedo Xr, Austedo |
| Abbvie INC. | $1,980.14 | 2021-2025 | |
| Abbott Laboratories | $1,243.82 | 2021-2025 | Proclaim, Octrode |
| Ucb, INC. | $471.57 | 2021-2025 | Briviact, Fintepla, Nayzilam |
| Alexion Pharmaceuticals, INC. | $468.32 | 2021-2025 | Ultomiris |
| Emd Serono, INC. | $396.54 | 2021-2025 | Mavenclad |
| Pfizer INC. | $372.96 | 2023-2025 | |
| Amgen INC. | $331.07 | 2021-2025 | Uplizna |
| Vanda Pharmaceuticals INC. | $286.31 | 2024-2025 | Ponvory |
| Lundbeck LLC | $277.38 | 2021-2025 | Vyepti |
| Genzyme Corporation | $270.50 | 2021-2025 | |
| Sk Life Science, INC. | $247.07 | 2023-2025 | |
| Biogen, INC. | $221.43 | 2022-2025 | Vumerity, Tysabri, Skyclarys |
| Otsuka America Pharmaceutical, INC. | $209.48 | 2023-2025 | Rexulti, Nuedexta |
| Argenx US, INC. | $193.85 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Flick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.